Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Antiobesity Market Set To Climb From $4.47 Billion In 2026 To $6.55 Billion By 2030
The antiobesity market has seen substantial expansion in recent years. Its valuation is anticipated to climb from $4.1 billion in 2025 to $4.47 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.0%. This historic growth can be attributed to several factors including a rise in global obesity rates, the limited effectiveness of lifestyle-only interventions, the availability of appetite suppressants, an increasing burden of metabolic disorders, and physician-guided weight management efforts.
The antiobesity market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $6.56 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this growth during the projected period include the rising incidence of diabetes and obesity, advancements in hormone-based medications, broader reimbursement coverage, heightened awareness regarding obesity, and the demand for effective long-term weight loss methods. Key trends for the forecast duration encompass the swift uptake of GLP-1 based treatments, an increasing inclination towards prescribed weight loss medications, the growing application of combined antiobesity therapies, a heightened emphasis on sustained weight management, and improved access to obesity treatments.
Get A Free Sample Report With In-Depth Market Insights:
Antiobesity Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of obesity is expected to boost the expansion of the anti-obesity drugs market in the future. Obesity, a persistent metabolic condition marked by the excessive buildup of body fat, elevates the likelihood of severe health issues such as diabetes, cardiovascular ailments, osteoarthritis, and specific types of cancer. This growing prevalence of obesity stems from a higher intake of ultra-processed foods rich in sugars, unhealthy fats, and refined carbohydrates, coupled with inactive lifestyles that decrease physical exertion. The heightened incidence of obesity is driving demand for effective medical interventions for obesity, supportive weight management approaches, and sustained treatment options to lessen related health dangers and enhance patient results. For example, data from March 2024, provided by the World Obesity Federation, a UK-based body dedicated to obesity research and advocacy, indicates that by 2035, an estimated 79% of adults who are overweight or obese, and 88% of children who are overweight or obese, are anticipated to reside in low and middle income countries. Consequently, the escalating rate of obesity is fueling the expansion of the anti-obesity drugs market.
Antiobesity Market Segment Analysis Spotlighting Growth Areas
The antiobesity market covered in this report is segmented –
1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
Subsegments:
1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin
2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide
Antiobesity Market Industry Trends: What’s Reshaping Demand?
Major companies within the antiobesity market are prioritizing product innovation and the development of new formulations, such as dual glucose-dependent insulinotropic peptide receptor agonists, with the goal of providing more significant weight loss, improved metabolic health, and better patient tolerability. These therapies harness synergistic actions on appetite suppression, insulin sensitivity, and energy expenditure to offer superior efficacy compared to earlier generation GLP-1-only treatments. For example, in December 2024, Eli Lilly, a US-based pharmaceutical company, obtained FDA approval for Zepbound (tirzepatide), making it the first and only prescription dual GIP/GLP-1 agonist sanctioned for chronic weight management. Tirzepatide has demonstrated robust weight-loss effectiveness, with participants in phase 3 trials achieving considerable reductions in body weight. With this new indication, Zepbound is expected to reinforce Lilly’s leadership in the precision obesity therapy domain, meeting the increasing demand for long-acting, highly effective treatments.
Antiobesity Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the antiobesity market are Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd.
View The Full Antiobesity Market Report:
Antiobesity Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the anti-obesity market in 2025. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
